Theravance Biopharma, Inc. (TBPH)
17.07
+0.04
(+0.23%)
USD |
NASDAQ |
Sep 02, 16:00
17.07
0.00 (0.00%)
Pre-Market: 20:00
Theravance Biopharma Cash and Short Term Investments (Quarterly) : 387.66M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 387.66M |
| March 31, 2026 | 394.67M |
| December 31, 2025 | 315.36M |
| September 30, 2025 | 329.68M |
| June 30, 2025 | 338.80M |
| March 31, 2025 | 130.86M |
| December 31, 2024 | 88.35M |
| September 30, 2024 | 91.36M |
| June 30, 2024 | 96.08M |
| March 31, 2024 | 99.98M |
| December 31, 2023 | 102.43M |
| September 30, 2023 | 134.00M |
| June 30, 2023 | 167.45M |
| March 31, 2023 | 241.26M |
| December 31, 2022 | 327.48M |
| September 30, 2022 | 486.83M |
| June 30, 2022 | 132.85M |
| March 31, 2022 | 147.52M |
| December 31, 2021 | 173.46M |
| September 30, 2021 | 216.21M |
| June 30, 2021 | 264.95M |
| March 31, 2021 | 209.97M |
| December 31, 2020 | 292.94M |
| September 30, 2020 | 358.35M |
| June 30, 2020 | 438.34M |
| Date | Value |
|---|---|
| March 31, 2020 | 487.03M |
| December 31, 2019 | 280.83M |
| September 30, 2019 | 327.18M |
| June 30, 2019 | 396.07M |
| March 31, 2019 | 434.06M |
| December 31, 2018 | 505.28M |
| September 30, 2018 | 300.41M |
| June 30, 2018 | 352.90M |
| March 31, 2018 | 418.53M |
| December 31, 2017 | 348.57M |
| September 30, 2017 | 335.00M |
| June 30, 2017 | 361.82M |
| March 31, 2017 | 392.77M |
| December 31, 2016 | 501.10M |
| September 30, 2016 | 230.48M |
| June 30, 2016 | 249.68M |
| March 31, 2016 | 179.88M |
| December 31, 2015 | 172.43M |
| September 30, 2015 | 195.97M |
| June 30, 2015 | 210.99M |
| March 31, 2015 | 236.24M |
| December 31, 2014 | 254.61M |
| September 30, 2014 | 284.72M |
| June 30, 2014 | 349.20M |
| March 31, 2014 | 0.00 |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Zymeworks, Inc. | 270.70M |
| Viatris, Inc. | 1.410B |
| Ocular Therapeutix, Inc. | 598.64M |
| ANI Pharmaceuticals, Inc. | 375.87M |
| Corcept Therapeutics, Inc. | 308.20M |